The store will not work correctly when cookies are disabled.
2,3-Dichloro-N-(5-methoxy-1-methyl-1H-indazol-4-yl)benzenesulfonamide
ID: ALA4088688
PubChem CID: 137642528
Max Phase: Preclinical
Molecular Formula: C15H13Cl2N3O3S
Molecular Weight: 386.26
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2c(cnn2C)c1NS(=O)(=O)c1cccc(Cl)c1Cl
Standard InChI: InChI=1S/C15H13Cl2N3O3S/c1-20-11-6-7-12(23-2)15(9(11)8-18-20)19-24(21,22)13-5-3-4-10(16)14(13)17/h3-8,19H,1-2H3
Standard InChI Key: DTQSJIWYWKVBLC-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
28.7559 -13.4458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.1710 -12.7304 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
28.3439 -12.7287 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.8897 -13.1398 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.1724 -11.9023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8886 -11.4934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8875 -10.6671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1700 -10.2540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4520 -10.6732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4566 -11.4982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3761 -14.1257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3723 -15.4641 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.8608 -14.7968 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5866 -15.2056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5928 -14.3824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8841 -13.9671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1687 -14.3739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1663 -15.2004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8756 -15.6119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6250 -16.2517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6042 -11.9082 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
30.6033 -10.2526 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
28.4543 -13.9570 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.7361 -14.3672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
2 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 15 1 0
14 12 1 0
12 13 1 0
13 11 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 20 1 0
16 4 1 0
6 21 1 0
7 22 1 0
17 23 1 0
23 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 386.26 | Molecular Weight (Monoisotopic): 385.0055 | AlogP: 3.69 | #Rotatable Bonds: 4 |
Polar Surface Area: 73.22 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.09 | CX Basic pKa: 1.90 | CX LogP: 2.96 | CX LogD: 2.15 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.74 | Np Likeness Score: -1.87 |
References
1. Miah AH, Champigny AC, Graves RH, Hodgson ST, Percy JM, Procopiou PA.. (2017) Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists., 25 (20): [PMID:28801066] [10.1016/j.bmc.2017.07.052] |